3-cyclobutene-1,2-dione has been researched along with kb 141 in 1 studies
| Studies (3-cyclobutene-1,2-dione) | Trials (3-cyclobutene-1,2-dione) | Recent Studies (post-2010) (3-cyclobutene-1,2-dione) | Studies (kb 141) | Trials (kb 141) | Recent Studies (post-2010) (kb 141) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 25 | 0 | 5 |
| Protein | Taxonomy | 3-cyclobutene-1,2-dione (IC50) | kb 141 (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0224 | |
| Thyroid hormone receptor beta | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bandyopadhyay, D; Gandhi, N; Jain, MR; Jogiya, D; Joharapurkar, A; Modi, H; Patel, PR; Raval, P; Raval, S; Soni, K; Yevale, D | 1 |
1 other study(ies) available for 3-cyclobutene-1,2-dione and kb 141
| Article | Year |
|---|---|
Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor beta (TR-beta) selective ligands.
Topics: Chemistry, Pharmaceutical; Crystallography, X-Ray; Cyclobutanes; Drug Design; Humans; Ligands; Luciferases; Models, Chemical; Molecular Conformation; Phenyl Ethers; Phenylacetates; Protein Binding; Structure-Activity Relationship; Thyroid Gland; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta | 2008 |